...
首页> 外文期刊>Polymers >The Influence of Lyophilized EmuGel Silica Microspheres on the Physicomechanical Properties, In Vitro Bioactivity and Biodegradation of a Novel Ciprofloxacin-Loaded PCL/PAA Scaffold
【24h】

The Influence of Lyophilized EmuGel Silica Microspheres on the Physicomechanical Properties, In Vitro Bioactivity and Biodegradation of a Novel Ciprofloxacin-Loaded PCL/PAA Scaffold

机译:冻干的EmuGel二氧化硅微球对新型环丙沙星PCL / PAA支架的物理力学性能,体外生物活性和生物降解的影响

获取原文

摘要

A new composite poly(caprolactone) (PCL) and poly(acrylic acid) (PAA) (PCL:PAA 1:5) scaffold was synthesized via dispersion of PCL particles into a PAA network. Silica microspheres (Si) (2–12 μm) were then prepared by a lyophilized micro-emulsion/sol-gel (Emugel) system using varying weight ratios. The model drug ciprofloxacin (CFX) was used for in situ incorporation into the scaffold. The physicochemical and thermal integrity, morphology and porosity of the system was analyzed by X-Ray Diffraction (XRD), Attenuated Total Refelctance Fourier Transform Infrared (ATR-FTIR), Differential Scanning Calorimetry (DSC), SEM, surface area analysis and liquid displacement, respectively. The mechanical properties of the scaffold were measured by textural analysis and in vitro bioactivity, biodegradation and pH variations were evaluated by XRD, FTIR and SEM after immersion in Simulated Body Fluid (SBF). The in vitro and in vivo studies of the prepared scaffold were considered as future aspects for this study. CFX release was determined in phosphate buffer saline (PBS) (pH 7.4; 37 °C). The incorporation of the Si microspheres and CFX into the scaffold was confirmed by XRD, FTIR, DSC and SEM, and the scaffold microstructure was dependent on the concentration of Si microspheres and the presence of CFX. The system displayed enhanced mechanical properties (4.5–14.73 MPa), in vitro bioactivity, biodegradation and controlled CFX release. Therefore, the PCL/PAA scaffolds loaded with Si microspheres and CFX with a porosity of up to 87% may be promising for bone tissue engineering.
机译:通过将PCL颗粒分散到PAA网络中,合成了一种新型的复合聚己内酯(PCL)和聚丙烯酸(PAA)(PCL:PAA 1:5)支架。然后通过冻干微乳液/溶胶-凝胶(Emugel)系统使用不同的重量比制备二氧化硅微球(Si)(2-12μm)。模型药物环丙沙星(CFX)用于原位掺入支架。通过X射线衍射(XRD),衰减全反射傅里叶变换红外(ATR-FTIR),差示扫描量热法(DSC),SEM,表面积分析和液体位移分析了系统的物理化学和热完整性,形态和孔隙率, 分别。支架的机械性能通过组织分析进行测量,并在浸入模拟体液(SBF)后通过XRD,FTIR和SEM评估体外生物活性,生物降解和pH值变化。制备的支架的体外和体内研究被认为是该研究的未来方面。在磷酸盐缓冲盐水(PBS)(pH 7.4; 37°C)中确定CFX释放。通过XRD,FTIR,DSC和SEM证实了Si微球和CFX结合到支架中,并且支架微结构取决于Si微球的浓度和CFX的存在。该系统显示出增强的机械性能(4.5–14.73 MPa),体外生物活性,生物降解和受控的CFX释放。因此,孔隙度高达87%的装有Si微球和CFX的PCL / PAA支架对于骨组织工程而言可能很有希望。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号